site sponsored by
Tag Archive | "over-the-past"
&h=57&w=100&zc=1&q=80" alt="How many “talented people” have lost jobs in the pharma industry this year? A response to John Lechleiter on America’s Growing Innovation Gap" class="th" />
Tags: avandia-fallout, country, data, marketing-excel, medications, oracle, over-the-past, pharmaceutical, sales, slowly-draining, study
How many “talented people” have lost jobs in the pharma industry this year? A response to John Lechleiter on America’s Growing Innovation Gap
Posted on 10 July 2010
Posted in DTCComments (0)
Tags: drug, DTC, environment, industry, oracle, over-the-past, passion, pharmaceutical
A response to John Lechleiter on America’s Growing Innovation Gap
Posted on 09 July 2010
Posted in DTCComments (0)
Tags: amgen-ventures, clinical-trials, million-venture, over-the-past, quogue-capital, rapidly-advance, seattle-times, technology, these-programs
Calistoga banks $40M Series C for pivotal trial work
Posted on 30 June 2010
Posted in Top NewsComments (0)
Tags: five-late-stage, from-the-market, medimmune, over-the-past, panel-members, past, pfizer, pipeline-snafus, tells-the-wire, upon-completion
Analysts fret over Pfizer’s litany of pipeline snafus
Posted on 25 June 2010
Posted in Top NewsComments (0)
Tags: arqule, asco 2010, biotech, celldex therapeutics, gtx, higher-response, highlights, light-at-asco, over-the-past
The ASCO roundup: ArQule drug flunks a mid-stage test
Posted on 08 June 2010
Posted in Top NewsComments (0)
Tags: #fdasm #hcsm, careers, connected, goods-companies, internet, marketing, over-the-past, Social Media, strategy, think-consumers
FDA and social media: Who the hell cares ?
Posted on 14 May 2010
Posted in DTCComments (0)
Tags: before-the-end, celtic-pharma, clinical-trials, geoff-porges, javelin pharmaceuticals, market, onto-the-market, over-the-past, planned-before, produce-pivotal, project, race, spotlight, study
Hepatitis C drug developers in race to win "warehoused" patients
Posted on 19 April 2010
Posted in Top NewsComments (0)
Tags: announced-today, biotech, biotech venture capital, biotech-venture, delivery, design, industry, oracle, over-the-past, pricewaterhouse, venture-capital
VC dips in Q1, but biotech still leads the pack
Posted on 16 April 2010
Posted in Top NewsComments (0)
Tags: antidepressant, backing, biotech, gain-approval, galen, james-fares, management, management-team, nautilus, nautilus neurosciences, over-the-past, tailwind, william-blair
Nautilus gets funding to support migraine drug launch
Posted on 13 April 2010
Posted in Top NewsComments (0)
Tags: antidepressant, backing, biotech, drugmakers, galen, licensing deals, management-team, nautilus neurosciences, over-the-past, scientists, swiss, tailwind, the-partnering
Roche: Still looking for deals in 2010
Posted on 13 April 2010
Posted in Top NewsComments (0)
Ask Our Experts
Heather R. Powell
Regulatory
Dawn Obermoeller
Social Media
Jonathan Richman
Non-Personal Promotion
Optimize RX
Internet Marketing & Analytics
Share Your Knowledge
We are always seeking seasoned pharmaceutical marketing professonals as contributors. If you have a strong background in pharmacetical marketing, and are interested in sharing your skills and knowledge with our community, or syndicating your existing blog posts, please click here.
- Popular
- Latest
- Comments
- Tags
- Subscribe
- Glaxo’s Avandia Should Be Pulled From U.K. Market, BMJ Chief Editor Says
- Aurobindo Signs Agreement to Supply Antibiotic, Heart Drugs to AstraZeneca
- Pressure on GSK as calls for Avandia withdrawal gather pace
- Ingenix Consulting – Trade print ad – USA 2010
- Rasilez HCT – HCP print ad – France 2010
- Velmetia – HCP print ad – France 2010
- Midol – DTC print ad – USA 2010
- Champix – HCP print ad – Belgium 2010
- Chiquita – HCP print ad – Belgium 2010
- Janumet – HCP print ad – Belgium 2010
- Optimize RX: yep - recvd - thanks - how much daily u.v.'s r u g...
- JMB: This is another bashing article from an author who...
- Martin: It's just silly of you to obsess over the possibil...
- Gregg Feris: Jon, Thanks for the in depth reply. I like the ...
- Doc: Why should Exxon have to pay this fine for somethi...
2009
adpharm
adpharm gallery
advertising
alpha
biotech
bnet
branded
business
development
drug
DTC
english
europe
fda
fierce-biotech
fierce pharma
gallery
hcp
health
industry
internet
largest
marketing
motley-fool
News
north
north america
north_america
online
online-pharmaceutical
pharma
Print
print_ad
Regulatory
sales
seeking-alpha
single-page
Social Media
technology
the-gallery
the-largest
time
usa
wsj
Stay up to date
- Subscribe to the RSS Feed
